Brexpiprazole for anxiety symptoms in schizophrenia: a pooled analysis of short- and long-term trials
Exploratory analyses suggest that brexpiprazole may help in the management of anxiety symptoms, functioning, and patient life engagement - important outcomes for people with schizophrenia.
Authors
- Zahinoor Ismail (ORCID: https://orcid.org/0000-0002-5529-3731)
- Shivani Kapadia (ORCID: https://orcid.org/0000-0002-1683-4742)
- Anton M. Palma (ORCID: https://orcid.org/0000-0003-1009-4701)
- Anja Farovik
- Murat Yildirim (ORCID: https://orcid.org/0000-0001-6192-1047)
Institutions
- Allen Institute for Brain Science (US)
- Lundbeck (Denmark) (DK)
- University of Exeter (GB)
- Otsuka (United States) (US)
- O'Brien Institute (AU)
- Otsuka Pharmaceutical (Spain) (ES)
- Health & Life (Taiwan) (TW)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2025-08-03
- DOI
- https://doi.org/10.1080/03007995.2025.2552286
- Citations
- 1
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47